Sinovac Biotech Ltd

SVQ

Company Profile

  • Business description

    Sinovac Biotech Ltd is a fully integrated China-based biopharmaceutical company focused on the research, development, manufacturing and commercialization of vaccines for the prevention of human infectious diseases, including certain diseases with unmet medical needs. It has developed a comprehensive vaccine portfolio covering hepatitis A, hepatitis B, hand, foot and mouth disease ("HFMD") caused by enterovirus 71 ("EV71"), seasonal and pandemic influenza, COVID-19, pneumococcal disease, poliomyelitis, mumps, varicella, rabies and tetanus. The Company operates exclusively in the research, development, manufacture, and commercialization of vaccines sector. The Company's business is considered as operating in one segment. It has presence in Chinese Mainland, and Outside Chinese Mainland.

  • Contact

    No.39, Shangdi Xi Road
    Haidan District
    Beijing100085
    CHN

    T: +86 1082799800

    E: [email protected]

    http://www.sinovac.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    2,602

Stocks News & Analysis

stocks

Pure-play data center share raises capital to fund AI demand

Funding the next wave of data center growth.
stocks

Chart of the Week: BHP’s growth story faces a reality check

China’s slowing economy could weigh on BHP’s future growth.
stocks

3 best ASX growth stocks to buy for the long term

Here’s three high-quality growth companies with wide moats.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,959.6053.40-0.59%
CAC 408,377.864.57-0.05%
DAX 4024,915.4984.04-0.34%
Dow JONES (US)52,552.97105.67-0.20%
FTSE 10010,572.2456.320.54%
HKSE24,753.08255.52-1.02%
NASDAQ25,881.95387.28-1.47%
Nikkei 22564,027.522,808.02-4.20%
NZX 50 Index13,622.667.880.06%
S&P 5007,533.7738.63-0.51%
S&P/ASX 2008,770.4046.40-0.53%
SSE Composite Index3,843.7138.71-1.00%

Market Movers